down arrow

Marksans Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
204.05
9.55 (4.91%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
1,232.54
1,031.27
886.33
710.16
687.62
501.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,232.54
1,031.27
886.33
710.16
687.62
501.43
Raw Material Cost
375.69
326.45
320.93
283.55
209.24
150.45
Purchase of Finished goods
301.56
200.00
88.55
39.27
96.18
60.76
(Increase) / Decrease In Stocks
-157.07
-30.97
28.56
14.86
-2.16
45.72
Employee Cost
164.64
139.37
116.29
103.84
86.58
81.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
283.61
180.51
178.88
131.20
144.61
-353.47
Total Expenditure (Excl Depreciation)
968.43
815.36
733.20
572.72
534.45
-14.77
Operating Profit (PBDIT) excl Other Income
264.11
215.91
153.13
137.44
153.17
516.20
Other Income
26.01
29.09
30.65
14.45
3.85
10.06
Operating Profit (PBDIT)
290.12
245.00
183.78
151.89
157.02
526.26
Interest
5.56
3.20
4.34
2.47
3.48
5.06
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
284.56
241.80
179.44
149.42
153.54
521.20
Depreciation
39.95
31.21
25.17
14.86
26.24
9.71
Profit Before Tax
244.62
210.59
154.28
134.56
127.30
61.27
Tax
57.79
56.31
33.97
25.67
27.20
12.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.83
154.29
120.31
108.89
100.10
48.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
186.83
154.29
120.31
108.89
100.10
48.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.36
-2.11
0.66
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
185.47
152.18
120.97
108.89
100.10
48.45
Equity Capital
45.32
45.32
40.42
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,236.08
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.09
3.36
2.99
2.66
2.45
1.18
Diluted Earnings per share
4.09
3.36
2.99
2.62
2.41
1.15
Operating Profit Margin (Excl OI)
21.43%
20.94%
17.28%
19.35%
22.28%
102.95%
Gross Profit Margin
23.09%
23.45%
20.25%
21.04%
22.33%
103.94%
PAT Margin
15.16%
14.96%
13.57%
15.33%
14.56%
9.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 19.52% vs 16.35% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 21.88% vs 25.80% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 22.32% vs 41.00% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 73.75% vs -26.27% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Marksans Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,232.54
5,969.93
-4,737.39
-79.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,232.54
5,969.93
-4,737.39
-79.35%
Raw Material Cost
375.69
934.97
-559.28
-59.82%
Purchase of Finished goods
301.56
857.27
-555.71
-64.82%
(Increase) / Decrease In Stocks
-157.07
-104.82
-52.25
-49.85%
Employee Cost
164.64
1,280.21
-1,115.57
-87.14%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
283.61
1,470.50
-1,186.89
-80.71%
Total Expenditure (Excl Depreciation)
968.43
4,438.13
-3,469.70
-78.18%
Operating Profit (PBDIT) excl Other Income
264.11
1,531.80
-1,267.69
-82.76%
Other Income
26.01
210.03
-184.02
-87.62%
Operating Profit (PBDIT)
290.12
1,741.83
-1,451.71
-83.34%
Interest
5.56
18.01
-12.45
-69.13%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
284.56
1,723.82
-1,439.26
-83.49%
Depreciation
39.95
213.36
-173.41
-81.28%
Profit Before Tax
244.62
1,510.46
-1,265.84
-83.80%
Tax
57.79
314.99
-257.20
-81.65%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
186.83
1,195.47
-1,008.64
-84.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
186.83
1,195.47
-1,008.64
-84.37%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
-1.36
-11.99
10.63
88.66%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
185.47
1,189.96
-1,004.49
-84.41%
Equity Capital
45.32
40.06
5.26
13.13%
Face Value
1.00
1.00
0.00
Reserves
2,236.08
0.00
2,236.08
Earnings per share (EPS)
4.09
29.70
-25.61
-86.23%
Diluted Earnings per share
4.09
29.65
-25.56
-86.21%
Operating Profit Margin (Excl OI)
21.43%
25.66%
0.00
-4.23%
Gross Profit Margin
23.09%
28.88%
0.00
-5.79%
PAT Margin
15.16%
20.13%
0.00
-4.97%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,232.54 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 19.52% vs 16.35% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 185.47 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 21.88% vs 25.80% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 264.11 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 22.32% vs 41.00% in Sep 2023

Half Yearly - Interest
Interest 5.56 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 73.75% vs -26.27% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.43%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023